Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra.

ABSTRACT:

Background

Andorra is a small country located in the Pyrenees attracting millions of visitors for tourism, mostly associated with skiing, and nature-related activities. As its neighbouring countries, Spain and France, it has been heavily affected by the COVID-19 pandemic. We estimated SARS-CoV-2 seroprevalence in the entire country by universal serological testing under a lockdown environment.

Methods

A total of 77,543 inhabitants of Andorra were invited to participate in the study. From 4-28 May, 2020, two cross sectional serological surveys were conducted using a rapid serological test (nCOV IgG/IgM) on a finger prick blood sample in 59 drive-through or walk-through checkpoints, all over Andorra. We calculated seroprevalence of antibodies against SARS-CoV-2 and analysed th

SUBMITTER: Royo-Cebrecos C 

PROVIDER: S-EPMC8454851 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature